While acute mortality is low, death can occur from long term complications.[15] Humans exposed to a non-disabling dose of 12 mg-min/m3 will have signs of mild discomfort and conjunctival injection. With a more disabling dose of 60 mg-min/m3, humans will experience generalized conjunctivas, edema, photophobia and eye irritation.